BIGBEAR
PHARMACEUTICAL
pecifically indicated for preventing complications caused by cytomegalovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplantation.
AuthenticGuaranteeFast DeliveryPrivacy FDA Approval AnnouncementYesterday, the U.S. Food and Drug Administration (FDA) approved an extended duration of use for Prevymis (letermovir), from 1···【More】
Update: 09 Mar,2026Source: BigbearViews: 111
FDA Approval AnnouncementAccording to a press release from Merck & Co., Inc. dated June 6, the U.S. Food and Drug Administration (FDA) has approve···【More】
Update: 09 Mar,2026Source: BigbearViews: 99
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
